Akari Therapeutics Plc · NASDAQ:AKTX
Gaslightwala Abizer exercised options for 27,066 Akari Therapeutics Plc shares (Form 4)
Traded Oct 14, 2026 · Filed Oct 16, 2026
On Oct 14, 2026, Gaslightwala Abizer (Director, CEO) exercised options for 27,066 Akari Therapeutics Plc shares at US$0.00 for US$11, leaving 41,173 shares. Filed Oct 16, 2026 (Form 4).
- Options exercised
- 27,066 shares
- Price
- US$0.00
- Value
- US$11
- Holding after
- 41,173 shares
- Trading plan
- No
- Role
- Director, CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 14, 2026 | American Depositary Shares representing Ordinary Shares | Option exercise | 19,333 | US$0.00 | 33,440 | Direct |
| Oct 14, 2026 | American Depositary Shares representing Ordinary Shares | Option exercise | 7,733 | US$0.00 | 41,173 | Direct |
Source
Download original · View original at SEC